Core Viewpoint - Zhonghong Medical announced that its subsidiary, Zhonghong Medical Supplies (Hainan) Co., Ltd., has obtained the Medical Device Registration Certificate from the Hainan Provincial Drug Administration for a disposable nutrition pump tube medical device [1] Group 1 - The approval of the medical device registration certificate indicates a significant regulatory milestone for the company [1] - The registered product is a disposable nutrition pump tube, which is essential for medical applications [1]

Core Viewpoint - 中红医疗 is primarily engaged in the production and sales of medical and industrial disposable protective gloves, with a significant focus on overseas markets and ODM direct sales model [2][9]. Group 1: Company Overview - 中红医疗 is located in Tangshan, Hebei Province, and was established on December 22, 2010, with its listing date on April 27, 2021 [9]. - The company's main business revenue composition includes health protection products (89.48%), safety infusion products (6.22%), and innovative incubation products (4.30%) [9]. - As of June 30, 2025, 中红医疗 had a total market capitalization of 56.27 billion yuan [1]. Group 2: Financial Performance - For the first half of 2025, 中红医疗 achieved operating revenue of 1.238 billion yuan, representing a year-on-year growth of 7.76%, while the net profit attributable to the parent company was 5.7429 million yuan, a decrease of 82.35% year-on-year [10]. - The company reported that 81.56% of its revenue comes from overseas, benefiting from the depreciation of the RMB [4]. Group 3: Product and Innovation - 中红医疗 showcased its products at the 12th Beijing Pet Expo, highlighting the UniFusion SP50 Vet and UniFusion VP50 Vet veterinary infusion pumps, which feature IP34 waterproof design and dual CPU architecture [2]. - The company emphasizes innovation and digital technology integration in product development, aiming to provide high-quality, innovative medical consumables and equipment [3]. Group 4: Market Position and Shareholder Information - 中红医疗 is classified as a state-owned enterprise, with the ultimate controller being the State-owned Assets Supervision and Administration Commission of the Xiamen Municipal People's Government [5]. - As of June 30, 2025, the number of shareholders was 20,200, an increase of 0.40% from the previous period, with an average of 19,502 circulating shares per person, up by 9.52% [10].

Core Viewpoint - Zhonghong Medical (300981.SZ) announced that its subsidiary, Zhonghong Medical Supplies (Hainan) Co., Ltd., has recently obtained the Medical Device Registration Certificate from the Hainan Provincial Drug Administration for its disposable nutrition pump tube medical device, which will enhance the company's product offerings in the nutrition pump consumables sector and strengthen its competitive edge [1] Group 1 - The acquisition of the Medical Device Registration Certificate is a significant milestone for Zhonghong Medical, as it allows the company to expand its product categories in the nutrition pump consumables field [1] - This development is expected to create brand and technological advantages for the company, further enhancing its overall competitiveness [1]

Core Viewpoint - Zhonghong Medical (300981.SZ) announced that its subsidiary, Hainan Zhonghong, has obtained the Medical Device Registration Certificate from the Hainan Provincial Drug Administration for a disposable nutrition pump tube, valid until October 15, 2030. This product is designed for delivering nutritional fluids into the gastrointestinal tract. The acquisition of this registration certificate is expected to enhance the company's product offerings in the nutrition pump consumables sector, establishing brand and technological advantages, although actual sales performance and its impact on future company earnings remain uncertain [1]. Summary by Category - **Product Development** - The company has received approval for a new medical device, a disposable nutrition pump tube, which is intended for gastrointestinal nutrition delivery [1]. - The registration certificate is valid until October 15, 2030, indicating a long-term opportunity for the company in this product line [1]. - **Market Positioning** - The approval is expected to enrich the company's product categories within the nutrition pump consumables market, potentially strengthening its brand and technological edge [1]. - **Financial Impact** - There is uncertainty regarding the actual sales performance of the new product and its future impact on the company's earnings [1].

Core Viewpoint - The company has obtained a medical device registration certificate for a disposable nutrition pump tube, enhancing its product offerings in the nutrition pump consumables sector [1] Summary by Categories Product Registration - The subsidiary Zhonghong Medical Supplies (Hainan) Co., Ltd. has received the "People's Republic of China Medical Device Registration Certificate" from the Hainan Provincial Drug Administration [1] - The registered product is classified as a Class II medical device, with a validity period from October 14, 2025, to October 13, 2030 [1] Market Impact - The acquisition of this medical device registration certificate will enrich the company's product categories in the nutrition pump consumables field [1] - This development is expected to create brand and technological advantages, further enhancing the overall competitiveness of the company and its subsidiaries [1]

上述产品实际销售情况取决于未来市场的推广效果，产品销售及利润贡献具 有不确定性，目前尚无法预测上述产品对公司未来业绩的影响，敬请投资者谨慎 决策注意防范投资风险。 一、基本信息 注册人名称 产品名称 注册证编号 注册分类 注册证有效期 适用范围 中红医疗用 品（海南） 有限公司 一次性使用 营养泵管 琼械注准 20252140097 Ⅱ类 2025 年 10 月 14 日 至 2030 年 10 月 13 日 产品适用于向胃肠内输 送营养液。 一次性使用 营养泵管 琼械注准 20252140098 Ⅱ类 2025 年 10 月 16 日 至 2030 年 10 月 15 日 产品适用于向胃肠内输 送营养液。 证券代码：300981 证券简称：中红医疗 公告编号：2025-093 中红普林医疗用品股份有限公司 关于子公司中红医疗用品（海南）有限公司 获得医疗器械注册证的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 中红普林医疗用品股份有限公司（以下简称"公司"）子公司中红医疗用品 （海南）有限公司（以下简称"海南中红"）于近期取得了海南省药品监督管理 局 ...

证券代码：300981 证券简称：中红医疗 公告编号：2025-092 中红普林医疗用品股份有限公司 关于子公司江西科伦医疗器械制造有限公司完成医疗器械 变更注册的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 中红普林医疗用品股份有限公司（以下简称"公司"）子公司江西科伦医疗 器械制造有限公司于近期取得国家药品监督管理局颁发的《医疗器械变更注册 （备案）文件》。具体变更情况如下： 董事会 二〇二五年十月十五日 | 产品名称 | 注册证编号 | 注册分类 | 变更内容 | 备注 | | --- | --- | --- | --- | --- | | 一次性使用输 | 国械注准 | | | 本文件与"国械注准 | | | | Ⅲ类 | 型号规格、技术要求变更。 | 20163141379"注册证 | | 液器 带针 | 20163141379 | | | | | | | | | 共同使用。 | 二、对公司的影响及风险提示 上述医疗器械注册证的变更是在原有注册证的基础上根据相关标准进行的 相应变更。一次性使用输液器（带针）领域相关产品的实际销售情况取决于未来 ...

Core Viewpoint - 中红医疗 is primarily engaged in the export of medical devices and consumables, utilizing an ODM direct sales model to produce for overseas brand owners [2][4]. Group 1: Company Overview - 中红医疗 was established on December 22, 2010, and listed on April 27, 2021, focusing on the research, production, and sales of high-quality disposable protective gloves [9]. - The company's main revenue sources are health protection products (89.48%), safety infusion products (6.22%), and innovative incubation products (4.30%) [9]. - As of June 30, 2025, 中红医疗 reported a revenue of 1.238 billion yuan, a year-on-year increase of 7.76%, while net profit attributable to shareholders decreased by 82.35% to 5.7429 million yuan [10]. Group 2: Market Position and Performance - The company benefits from a high overseas revenue ratio of 81.56%, aided by the depreciation of the RMB [4]. - 中红医疗 is classified as a state-owned enterprise, with the ultimate control held by the Xiamen Municipal Government State-owned Assets Supervision and Administration Commission [5]. - The stock has a current market capitalization of 5.695 billion yuan, with a trading volume of 59.614 million yuan and a turnover rate of 1.16% [1]. Group 3: Product Innovation and Development - 中红医疗 emphasizes innovation through the integration of digital technology in product development, aiming to provide high-quality, innovative medical consumables and equipment [3]. - The company showcased its products at the 12th Beijing Pet Expo, highlighting the UniFusion SP50 Vet and UniFusion VP50 Vet veterinary infusion pumps, which feature IP34 waterproof design and dual CPU architecture [2]. Group 4: Shareholder and Financial Analysis - As of June 30, 2025, 中红医疗 had 20,200 shareholders, with an increase of 0.40% from the previous period, and an average of 19,502 circulating shares per person, up by 9.52% [10]. - The average trading cost of the stock is 14.58 yuan, with recent buying activity indicating weak accumulation [8].

Core Viewpoint - The company, Zhonghong Medical, is primarily engaged in the export of medical devices and consumables, utilizing an ODM direct sales model, which allows it to design and produce products for overseas brand owners [2][4]. Group 1: Business Overview - Zhonghong Medical's main business includes the research, production, and sales of high-quality nitrile gloves, PVC gloves, and other disposable protective gloves, with health protection products accounting for 89.48% of revenue [9]. - The company has a significant international presence, with 81.56% of its revenue coming from overseas markets, benefiting from the depreciation of the RMB [4]. - The company is state-owned, with the ultimate control held by the Xiamen Municipal Government State-owned Assets Supervision and Administration Commission [5]. Group 2: Product Innovation and Market Presence - Zhonghong Medical showcased its products at the 12th Beijing Pet Expo, highlighting its veterinary infusion pumps, which feature IP34 waterproof design and dual CPU architecture, catering to various clinical needs [2]. - The company emphasizes innovation through digital technology, aiming to develop high-quality, innovative medical consumables and equipment, positioning itself as a leading provider of intelligent medical solutions [3]. Group 3: Financial Performance - For the first half of 2025, Zhonghong Medical reported a revenue of 1.238 billion yuan, representing a year-on-year growth of 7.76%, while the net profit attributable to shareholders decreased by 82.35% to 5.7429 million yuan [10]. - The company has distributed a total of 1.251 billion yuan in dividends since its A-share listing, with 501 million yuan distributed over the past three years [11].

Core Viewpoint - The announcement indicates that the company’s subsidiary, Jiangxi Kelong Medical Device Manufacturing Co., Ltd., is participating in a centralized procurement project for disposable pressure extension tubes and syringes in Fujian Province, which may lead to selected products for procurement [1] Group 1 - The company’s subsidiary, Kelong Medical, is involved in a bidding process for a centralized procurement project in Zhangzhou, Fujian Province [1] - The procurement project includes disposable pressure extension tubes and syringes, indicating a focus on essential medical supplies [1] - The announcement suggests potential for increased sales and market presence if selected in the procurement process [1]